Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

New Studies Examine Impact of Poverty, Race, Ethnicity in Patients with SLE

Elizabeth Hofheinz, MPH, MEd  |  Issue: October 2017  |  October 17, 2017

mantinov / shutterstock.com

mantinov / shutterstock.com

To correctly address a problem, one must have a handle on its nuances—a clear understanding of what is linked and how. And thus far, when it comes to lupus, we haven’t reached the point of understanding those intricacies.

Things are heading in the right direction, however, with two new studies that get us much closer to untangling the relationships among lupus, poverty, race and ethnicity.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Edward Yelin, PhD, is professor emeritus at the University of California, San Francisco. His work, “A Prospective Study of the Impact of Current Poverty, History of Poverty, and Exiting Poverty on Accumulation of Disease Damage in SLE,” was recently published in Arthritis & Rheumatology.1

Dr. Yelin says, “We already know that racial and ethnic minorities are more likely to be diagnosed with lupus than are Caucasians. However, after the onset of the disease, it is not race or ethnicity that primarily drives the differences in outcomes. There is a solid history of literature indicating that it is poverty or other socioeconomic issues.”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

The question, says Dr. Yelin, is “Why?”

Dr. Yelin

Dr. Yelin

In an attempt to tease out the answer to this and other questions, Dr. Yelin and his colleagues followed 783 lupus patients from 2003 to 2015, focusing on the extent of disease damage experienced by each participant.

“One question that arose was, ‘Is it poverty itself that poses the problem, or is it something to do with the personality of those who tend to be poor?’ We postulated that the number of years a lupus patient had been poor has a strong relationship with how much disease damage they had suffered. Although we could not randomize people to poverty, we were able to observe whether people who left poverty had better outcomes—and indeed they did.”

Length of Time in Poverty Matters

Elaborating on this sociological dose-response relationship between poverty and lupus-related damage, Dr. Yelin notes, “We found that the longer people lived in poverty, the more disease damage they sustained. Those who were able to permanently transition out of poverty did have similar increases in damage as those who were never in poverty, but it was not as severe as those who remained poor.”

Given that lifting large numbers of patients out of poverty is a supremely challenging, long-term goal, Dr. Yelin and his colleagues wanted to find out what else was going on. Perhaps there were things occurring at a micro, daily level that could be amenable to improvements. And although they found them, the fact is that there are no simple answers.

Page: 1 2 3 4 | Single Page
Share: 

Filed under:ConditionsResearch RheumSystemic Lupus Erythematosus Tagged with:DiagnosisDisparitiesimpactincomeinequalityLupuspatient carepovertypregnancyracialResearchRheumatic DiseaserheumatologyrisksocioeconomicStressstudySystemic lupus erythematosus

Related Articles

    Antiphospholipid Antibody Testing Update

    January 13, 2012

    Successes, challenges, and controversies of diagnostic methods for APS

    APS: What Rheumatologists Should Know about Hughes Syndrome

    February 17, 2016

    The problem that dogs the work of all of those treating patients with antiphospholipid syndrome (APS) is the apparent lack of knowledge of the syndrome, both by the general public, as well as by swaths of the medical fraternity. Perhaps it was ever thus—a syndrome less than 40 years old could be described as new,…

    A Better Family Plan

    October 1, 2007

    How to minimize the risks of pregnancy for women with SLE

    Rheumatologists, Social Workers Collaborate to Help Patients with Lupus

    April 19, 2017

    At the Hospital for Special Surgery (HSS), New York, rheumatologists and social workers have found that an interdisciplinary approach to care for systemic lupus erythematosus (SLE) patients improves the overall patient experience. “Our goal is to help patients navigate the complex healthcare system,” says Jillian Rose, LCSW, MPH, assistant director, Community Engagement, Diversity & Research….

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences